Published in Neurol Clin Pract on April 01, 2013
How Do Clinicians Adjust Lamotrigine Doses and Use Lamotrigine Blood Levels?-A Q-PULSE Survey. Epilepsy Curr (2014) 0.77
Biosimilars in rheumatic diseases: structural and functional variability that may impact clinical and regulatory decisions. Clin Rheumatol (2016) 0.77
Medicare Part D payments for neurologist-prescribed drugs. Neurology (2016) 0.76
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Ann Pharmacother (2009) 3.36
Assessing bioequivalence of generic antiepilepsy drugs. Ann Neurol (2011) 3.30
Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia (2007) 1.70
From the Food and Drug Administration. JAMA (1999) 1.49
Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes. Epilepsia (2008) 1.44
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration. AAPS J (2012) 1.22
Generic antiepileptic drugs: current controversies and future directions. Epilepsy Curr (2008) 1.13
Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs. Curr Med Res Opin (2010) 1.11